title: Quality-adjusted life-years as decisionmaker tools to address limitations inherent in number-needed-to-treat/harm values.
authors.forename: Dennis W
authors.initials: DW
authors.lastname: Raisch
authors.forename: James J
authors.initials: JJ
authors.lastname: Nawarskas
mesh_terms: D003362:Cost-Benefit Analysis; D003657:Decision Making; D017850:Economics, Pharmaceutical / Q000706:statistics & numerical data*; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors; D019057:Quality-Adjusted Life Years; D012107:Research Design; D018570:Risk Assessment; D016896:Treatment Outcome
chemical_list: D019039:Platelet Glycoprotein GPIIb-IIIa Complex